- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- November 2023
- 147 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- April 2024
- 573 Pages
Global
From €5405EUR$5,600USD£4,637GBP
- Report
- November 2019
- 281 Pages
Asia Pacific
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- July 2019
- 194 Pages
Global
From €3074EUR$3,185USD£2,637GBP
€4392EUR$4,550USD£3,767GBP
- Report
- February 2024
- 74 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- January 2023
- 256 Pages
Global
From €5531EUR$5,730USD£4,744GBP
The Newborn Genetic Testing market is a subset of the larger Genomics market. It involves the use of genetic testing to identify genetic disorders in newborns. This type of testing is typically done shortly after birth and can help detect conditions such as Down Syndrome, cystic fibrosis, and other genetic disorders. The results of the tests can help guide medical decisions and provide parents with information about their child's health.
The Newborn Genetic Testing market is growing as more parents opt for testing and as technology advances. The tests are becoming more accurate and cost-effective, making them more accessible to a wider range of parents. Additionally, the tests are becoming more comprehensive, allowing for the detection of a wider range of genetic disorders.
Some companies in the Newborn Genetic Testing market include Illumina, Natera, and Invitae. These companies provide a range of genetic testing services, including newborn genetic testing. Show Less Read more